SCHEMBL9119694

SCHEMBL9119694

CC1(C)O[C@H](CN)[C@@H](CN)O1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1145900 1.00
SCHEMBL11473560 1.00
SCHEMBL584624 1.00
SCHEMBL9122867 0.89
SCHEMBL12880737 0.89
SCHEMBL12027382 0.89
SCHEMBL9122356 0.89
SCHEMBL1415542 0.87
SCHEMBL1415566 0.87
SCHEMBL4493542 0.87

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11365190-B2 Heterocyclic amides useful as protein modulators GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2022-06-21 US disclosed
EP-3440076-B1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS GLAXOSMITHKLINE IP DEV LTD (GB) 2022-06-01 EP disclosed
US-20210238172-A1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS AND METHODS OF USING THE SAME GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2021-08-05 US disclosed
US-20210139473-A1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2021-05-13 US disclosed
US-10981901-B1 Heterocyclic amides useful as protein modulators GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2021-04-20 US disclosed
EP-3440076-A1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS GlaxoSmithKline Intellectual Property Development Ltd (GB) 2019-02-13 EP disclosed
US-10189820-B2 Heterocyclic amides useful as protein modulators GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2019-01-29 US disclosed
US-20180105514-A1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-04-19 US disclosed
US-20180105514-A1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2018-04-19 US disclosed
WO-2017175147-A1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-10-12 WO disclosed
WO-2017175147-A1 HETEROCYCLIC AMIDES USEFUL AS PROTEIN MODULATORS GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) 2017-10-12 WO disclosed
WO-2016196393-A2 AUTOPHAGY-INHIBITING COMPOUNDS AND USES THEREOF PRESAGE BIOSCIENCES, INC. (US) 2016-12-08 WO disclosed
WO-2016196393-A2 AUTOPHAGY-INHIBITING COMPOUNDS AND USES THEREOF PRESAGE BIOSCIENCES, INC. (US) 2016-12-08 WO disclosed
US-5395947-A Antitumor agents SUNKYONG INDUSTRIES, LTD. (KR) 1995-03-07 US disclosed
EP-0586378-A1 NOVEL PLATINUM(II) COMPLEX AND PROCESSES FOR PREPARING THE SAME SUNKYONG INDUSTRIES LTD. (KR) 1994-03-16 EP disclosed
WO-1992016539-A1 NOVEL PLATINUM(II) COMPLEX AND PROCESSES FOR PREPARING THE SAME SUNKYONG INDUSTRIES LTD. (KR) 1992-10-01 WO disclosed
EP-0222522-B1 PLATINUM COORDINATION COMPOUNDS JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 1990-03-14 EP disclosed
US-4783452-A ANTITUMOR AGENTS JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 1988-11-08 US disclosed
EP-0222522-A2 Platinum coordination compounds JOHNSON MATTHEY PUBLIC LIMITED COMPANY (GB) 1987-05-20 EP disclosed